CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 116 filers reported holding CYTOMX THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $162,000 | -15.2% | 37,500 | 0.0% | 0.02% | +4.5% |
| Q3 2021 | $191,000 | -59.8% | 37,500 | -50.0% | 0.02% | -63.9% |
| Q2 2021 | $475,000 | -18.1% | 75,000 | 0.0% | 0.06% | -19.7% |
| Q1 2021 | $580,000 | +2.5% | 75,000 | +105.5% | 0.08% | -96.9% |
| Q2 2017 | $566,000 | -53.6% | 36,499 | -48.3% | 2.48% | -58.4% |
| Q1 2017 | $1,219,000 | +132.6% | 70,584 | +48.1% | 5.98% | +220.9% |
| Q4 2016 | $524,000 | -53.2% | 47,666 | -33.2% | 1.86% | -41.8% |
| Q3 2016 | $1,119,000 | +53.5% | 71,366 | 0.0% | 3.20% | +30.4% |
| Q2 2016 | $729,000 | – | 71,366 | – | 2.45% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,500,000 | $7,635,000 | 1.78% |
| Altium Capital Management LP | 1,233,642 | $6,279,000 | 1.65% |
| RA Capital Management | 3,500,000 | $17,815,000 | 0.25% |
| Soleus Capital Management, L.P. | 261,050 | $1,329,000 | 0.21% |
| Affinity Asset Advisors, LLC | 125,000 | $636,000 | 0.16% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,078,103 | $5,488,000 | 0.16% |
| Point72 Asset Management, L.P. | 6,303,025 | $32,082,000 | 0.14% |
| GSA CAPITAL PARTNERS LLP | 249,146 | $1,268,000 | 0.13% |
| Candriam S.C.A. | 3,305,940 | $16,826,000 | 0.11% |
| RTW INVESTMENTS, LP | 1,400,939 | $7,131,000 | 0.11% |